Benitec Biopharma (BNTC) Revenue & Revenue Breakdown
Benitec Biopharma Revenue Highlights
Latest Revenue (Y)
$75.00K
Latest Revenue (Q)
$6.00K
Main Segment (Y)
License
Main Geography (Y)
License
Benitec Biopharma Revenue by Period
Benitec Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $75.00K | 2.74% |
| 2022-06-30 | $73.00K | 23.73% |
| 2021-06-30 | $59.00K | -39.18% |
| 2020-06-30 | $97.00K | -99.14% |
| 2019-06-30 | $11.32M | 2384.76% |
| 2018-06-30 | $455.45K | 1.14% |
| 2017-06-30 | $450.31K | 29.96% |
| 2016-06-30 | $346.51K | -58.21% |
| 2015-06-30 | $829.13K | -18.53% |
| 2014-06-30 | $1.02M | 86.49% |
| 2013-06-30 | $545.73K | - |
Benitec Biopharma generated $75.00K in revenue during NA 2023, up 2.74% compared to the previous quarter, and up 16.47% compared to the same period a year ago.
Benitec Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $6.00K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $7.00K | -87.04% |
| 2023-03-31 | $54.00K | 285.71% |
| 2022-12-31 | $14.00K | -97.03% |
| 2022-09-30 | $472.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $48.00K | 92.00% |
| 2021-12-31 | $25.00K | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $2.00K | 100.00% |
| 2021-03-31 | $1.00K | - |
| 2020-12-31 | $1.00K | -98.18% |
| 2020-09-30 | $55.00K | -237.50% |
| 2020-06-30 | $-40.00K | -242.86% |
| 2020-03-31 | $28.00K | -63.64% |
| 2019-12-31 | $77.00K | 133.33% |
| 2019-09-30 | $33.00K | 8.89% |
| 2018-06-30 | $30.31K | -69.18% |
| 2018-03-31 | $98.32K | -56.87% |
| 2017-12-31 | $227.97K | 130.61% |
| 2017-09-30 | $98.85K | 22.39% |
| 2017-06-30 | $80.77K | -56.04% |
| 2017-03-31 | $183.73K | 81.64% |
| 2016-12-31 | $101.15K | 19.48% |
| 2016-09-30 | $84.66K | 63.84% |
| 2016-06-30 | $51.67K | -14.43% |
| 2016-03-31 | $60.39K | -20.80% |
| 2015-12-31 | $76.25K | -51.80% |
| 2015-09-30 | $158.20K | -52.40% |
| 2015-06-30 | $332.32K | -1372.59% |
| 2015-03-31 | $-26.11K | - |
Benitec Biopharma generated $6.00K in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 42.86% compared to the same period a year ago.
Benitec Biopharma Revenue Breakdown
Benitec Biopharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jun 23 | Jun 22 | Jun 20 |
|---|---|---|---|
| License | $75.00K | $73.00K | - |
| Grant | - | - | $5.00K |
Benitec Biopharma's latest annual revenue breakdown by segment (product or service), as of Jun 23: License (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|
| License | $1.00K | $1.00K | $55.00K |
| Service | - | - | - |
| Royalty | - | - | - |
Benitec Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: License (100.00%).
Benitec Biopharma Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 22 | Jun 20 | Jun 19 |
|---|---|---|---|
| License | $73.00K | - | - |
| Grant | - | $5.00K | - |
| AUSTRALIA | - | - | $14.63M |
Benitec Biopharma's latest annual revenue breakdown by geography, as of Jun 22: License (100.00%).
Benitec Biopharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CAPR | Capricor Therapeutics | $25.18M | $3.97M |
| SGTX | Sigilon Therapeutics | $12.94M | $5.90M |
| CBIO | Gyre Therapeutics | $794.00K | - |
| BNTC | Benitec Biopharma | $75.00K | $6.00K |
| APLM | Apollomics | - | - |
| BPTH | Bio-Path | - | - |
| ZURA | Zura Bio | - | - |
| NXTC | NextCure | - | - |
| ALRN | Aileron Therapeutics | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| ONCR | Oncorus | - | - |
| LABP | Landos Biopharma | - | - |
| VIRI | Virios Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| DFFN | CervoMed | - | - |
BNTC Revenue FAQ
What is Benitec Biopharma’s yearly revenue?
Benitec Biopharma's yearly revenue for 2023 was $75K, representing an increase of 2.74% compared to 2022. The company's yearly revenue for 2022 was $73K, representing an increase of 23.73% compared to 2021. BNTC's yearly revenue for 2021 was $59K, representing a decrease of -39.18% compared to 2020.
What is Benitec Biopharma’s quarterly revenue?
Benitec Biopharma's quarterly revenue for Q3 2024 was $6K, a 100.00% increase from the previous quarter (Q2 2024), and a -88.89% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). BNTC's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).
What is Benitec Biopharma’s revenue growth rate?
Benitec Biopharma's revenue growth rate for the last 3 years (2021-2023) was 27.12%, and for the last 5 years (2019-2023) was -99.34%.
What are Benitec Biopharma’s revenue streams?
Benitec Biopharma's revenue streams in n 23 are License
What is Benitec Biopharma’s main source of revenue?
For the fiscal year ending Jun 23, the largest source of revenue of Benitec Biopharma was License. This segment made a revenue of $75K, representing 100.00% of the company's total revenue.